Participant retention flowchart. by Carolin Oetzmann (11397968)

Subjects:

The clinical characteristic of patients. by Hai-bo Ai (20790405)

Raw data. by Jia Zhu (135506)

Subjects:

Linear trends of weekly prescription rates of NVBP varieties. by Chenxuan Zhu (22622476)

New visits, types of health events, procedure, and outcome of health events during all of 2020, and during the BR-period, Ramadan period, and AR-period. by Taizo Sakata (21567847)

Subjects:

Age and sex of patients who visited the PHC during all of 2020, and during the BR-period, Ramadan period, and AR-period. by Taizo Sakata (21567847)

Subjects:

Seven-day moving average number of PHC visits and health events during 2020. by Taizo Sakata (21567847)

Subjects:

Multivariable logistic regression analysis of the relationship of the date of a PHC visit with new visits, types of health events, procedure, and outcome of visits. by Taizo Sakata (21567847)

Subjects:

Age and sex of the refugee community in Camp 14 and in host communities. by Taizo Sakata (21567847)

Subjects:

Between the PCSO-524 group and the placebo group unpaired comparisons of the change between visits of quality of life and respiratory variables scores. by Nattapon Riengvirodkij (11268720)

Subjects:

A flow diagram outlining the number of dogs in each group during the study (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70). by Nattapon Riengvirodkij (11268720)

Subjects:

Distribution of quality of life and respiratory variables scores of all 3 visits (visit = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group... by Nattapon Riengvirodkij (11268720)

Subjects:

The baseline characteristics of classifications and body condition score of the 2 groups (frequencies) at entry (visit 1, day 0). by Nattapon Riengvirodkij (11268720)

Subjects:

Distribution of continuous variables of all 3 visits (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group. Results are shown as mea... by Nattapon Riengvirodkij (11268720)

Subjects:

Tricuspid regurgitation pressure gradient of all 17 dogs. by Nattapon Riengvirodkij (11268720)

Subjects:

Tricuspid regurgitation pressure gradient in the PCSO-524 and placebo groups. by Nattapon Riengvirodkij (11268720)

Subjects:

Clinical course of patient no. by Kazuyoshi Ohkawa (836847)

Subjects:

Study flow chart. by Raymond Atwine (18574812)

Subjects:

Bar graph showing proportion of NADCs. by Raymond Atwine (18574812)

Subjects:

Line graph showing the trends of ADCs and NADCS over the 10 years period. by Raymond Atwine (18574812)

Subjects: